Author

Matt Fisher

Institution: Haleon (United States)

Observed institution: Haleon (United States)

ORCID: 0000-0003-0014-4445

Observed ORCID: 0000-0003-0014-4445

OpenAlex ID: A5059081444

A Detailed Analysis of the Past 20 Years of US FDA-Approved Prescription to Over-the-Counter Switches

2023 · Matt Fisher, Kapil Rawal · Therapeutic Innovation & Regulatory Science · 8

The effect of doxepin 3 mg on sleep latency: a pooled analysis of two phase 3 trials

2025 · Matt Fisher, Mako Araga, et al. · Sleep And Breathing · 3

Pharmacologic treatment data from chronic insomnia studies and the application to individuals with acute insomnia, a narrative review

2026 · Andrew Krystal, Ruth Benca, et al. · Sleep Medicine Reviews · 2

Association of Oral Triptans and Other Oral Migraine Treatments With Cardiovascular Outcomes in Patients With a History of Cardiovascular Conditions

2025 · David W. Dodick, Matt Fisher, et al. · medRxiv · 1

Patient Factors in the Dose Selection of Oral Sumatriptan for Acute Migraine: A Post Hoc Analysis of Two Randomized Controlled Studies

2023 · Matt Fisher, Abhay Aher, et al. · Pain and Therapy · 1

Works count: 5

Citation count: 15

H-index: 2

I10-index: